Peter Virsik
Director de Operaciones en ESSA PHARMA INC. .
Fortuna: 68 826 $ al 30/04/2024
Cargos activos de Peter Virsik
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ESSA PHARMA INC. | Director de Operaciones | 01/08/2016 | - |
Historial de carrera de Peter Virsik
Antiguos cargos conocidos de Peter Virsik.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| XENOPORT, INC. | Corporate Officer/Principal | 01/01/2005 | 01/01/2015 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01/01/2000 | 01/01/2005 |
Formación de Peter Virsik.
| Kellogg School of Management | Masters Business Admin |
| University of Michigan | Graduate Degree |
| University of California, Berkeley | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 6 |
| Canadá | 2 |
Operativa
| Corporate Officer/Principal | 2 |
| Masters Business Admin | 1 |
| Graduate Degree | 1 |
Sectorial
| Health Technology | 4 |
| Consumer Services | 4 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| ESSA PHARMA INC. | Health Technology |
| GILEAD SCIENCES, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
XenoPort, Inc.
 XenoPort, Inc. Pharmaceuticals: MajorHealth Technology XenoPort, Inc. operated as a biopharmaceutical company. Its products included horizant and regnite. The company was founded by Ronald W. Barrett, William J. Dower and Mark A. Gallop on December 17, 1999 and was headquartered in Atlanta, GA. | Health Technology |
- Bolsa de valores
- Insiders
- Peter Virsik
- Experiencia